SMRI is an exchange-traded fund — it holds a basket of underlying assets rather than being a single operating company.
Company fundamentals like P/E, revenue, EPS and profit margins don't apply to a fund — its value comes from the assets it holds, not its own earnings. Use the price chart, options and model forecast below for fund-level analysis.
An institutional-grade, numbers-driven thesis on SMRI — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of July 4, 2026, TradersQuant's model rates Bushido Capital US Equity ETF (SMRI) 55/100 with a 12-month base-case forecast of $49.35 — +17.4% versus the current price of $42.03. Bushido Capital US Equity ETF trades at $42.03 in the Financial Services sector, with a market capitalisation of $614.9M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for SMRI is $49.35, implying +17.4% versus the current price. The model's 12-month scenario range runs from $44.17 (bear) to $57.21 (bull), with a base case of $49.35.
SMRI currently carries a TradersQuant composite score of 55/100, which we read as a neutral-to-watch signal. Our 12-month price target of $49.35 implies +17.4% from $42.03. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for SMRI is $49.35, about +17.4% versus the latest price of $42.03.
TradersQuant's 12-month model forecast for SMRI is a base case of $49.35, ranging from $44.17 (bear) to $57.21 (bull), an expected return of +17.4%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for SMRI over the next 12 months is $49.35 in the base case (bear $44.17, bull $57.21), versus today's price of $42.03. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for SMRI — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates SMRI's fair value at $53.59, implying +27.5% of expected upside versus the current price.
Bushido Capital US Equity ETF does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
